The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Perfilova V.N.

Volgograd State Medical University

Muzyko E.A.

Volgograd State Medical University

Tikhaeva K.Yu.

Genome-Volga

Kustova M.V.

Volgograd State Medical University

Muhina A.V.

Volgograd State Medical University of the Ministry of Health of Russia

Fokina A.Y.

Volgograd State Medical University

Zhuravleva E.I.

Volgograd State Medical University

Study of athrombogenic and thrombogenic factors of the endothelium in women with an unexpected poor and suboptimal ovarian response during the treatment of infertility by methods of assisted reproductive technology

Authors:

Perfilova V.N., Muzyko E.A., Tikhaeva K.Yu., Kustova M.V., Muhina A.V., Fokina A.Y., Zhuravleva E.I.

More about the authors

Journal: Russian Journal of Human Reproduction. 2025;31(4): 56‑63

Read: 326 times


To cite this article:

Perfilova VN, Muzyko EA, Tikhaeva KYu, Kustova MV, Muhina AV, Fokina AY, Zhuravleva EI. Study of athrombogenic and thrombogenic factors of the endothelium in women with an unexpected poor and suboptimal ovarian response during the treatment of infertility by methods of assisted reproductive technology. Russian Journal of Human Reproduction. 2025;31(4):56‑63. (In Russ.)
https://doi.org/10.17116/repro20253104156

Recommended articles:
Reproductive aspe­cts in the treatment of colo­rectal endo­metriosis. Russian Journal of Human Reproduction. 2024;(6):140-148
The expe­rience of using the nasal form of GnRH agonists in in vitro fertilization programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):79-84

References:

  1. Klinicheskie rekomendacii. Zhenskoe besplodie. Odobreno Nauchno-prakticheskim Sovetom Ministerstva zdravooxraneniya Rossijskoj Federacii. 2024. Accessed June 20, 2025. (In Russ.). https://cr.minzdrav.gov.ru/view-cr/641_2
  2. Registr VRT. Otchet za 2021 god. Rossijskaya Associaciya Reprodukcii Cheloveka. Accessed June 20, 2025. (In Russ.). https://www.rahr.ru/d_registr_otchet/RegistrVRT_2021.pdf
  3. Kovalenko YaA, Chuprinenko LM. Structural and tructural and functional features of endometrium in patients undergoing in vitro fertilization. Sechenovskij vestnik. 2019;10(1):29-34. (In Russ.). https://doi.org/10.26442/22187332.2019.1.29-34
  4. van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, Fauser BC, Macklon NS. Optimum number of oocytes for a successful first IVF treatment cycle. Reproductive Biomedicine Online. 2006;13(4):476-480.  https://doi.org/10.1016/s1472-6483(10)60633-5
  5. Tikhaeva KYu, Gavrilova IS, Nazarov NO, Rogova LN, Povetkina VN, Shesternina NV, Tomilov EV, Dyachkova SYu. The role of medical, social and anthropogenic factors in the effectiveness of infertility treatment by methods of assisted reproductive technologies. Russian Journal of Human Reproduction. 2021;27(5):104-113. (In Russ.). https://doi.org/10.17116/repro202127051104
  6. Ferraretti AP, La Marca A, Fauser B CJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of «poor response» to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction. 2011;26(7):1616-1624. https://doi.org/10.1093/humrep/der092
  7. Stepanova TV, Ivanov AN, Tereshkina NE, Popyhova EB, Lagutina DD. Markers of endothelial dysfunction: pathogenetic role and diagnostic significance. Klinicheskaya laboratornaya diagnostika. 2019;64(1):34-41. (In Russ.). https://doi.org/10.18821/0869-2084-2019-64-1-34-41
  8. Moin ASM, Sathyapalan T, Diboun I, Elrayess MA, Butler AE, Atkin SL. Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome. Scientific Reports. 2021;11(1):5320. https://doi.org/10.1038/s41598-021-84586-y
  9. Ogawa S, Minakami H, Araki S, Ohno T, Motoyama M, Shibahara H, Sato I. A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome. Journal of Assisted Reproduction and Genetics. 2001;18(2):114-119.  https://doi.org/10.1023/a:1026590910462
  10. Kedem A, Aelion-Brauer A, Guo P, Wen D, Ding BS, Lis R, Cheng D, Sandler VM, Rafii S, Rosenwaks Z. Activated ovarian endothelial cells promote early follicular development and survival. Journal of Ovarian Research. 2017;10(1):64.  https://doi.org/10.1186/s13048-017-0354-z
  11. Kim GA, Lee Y, Kim HJ, Oh HJ, Kang SK, Ra JC, Lee BC. Intravenous human endothelial progenitor cell administration into aged mice enhances embryo development and oocyte quality by reducing inflammation, endoplasmic reticulum stress and apoptosis. The Journal of Veterinary Medical Science. 2018;80(12):1905-1913. https://doi.org/10.1292/jvms.18-0242
  12. Abudoukelimu M, Ba B, Kai Guo Y, Xu J. Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study. Medicine (Baltimore). 2022;101(31):e29854. https://doi.org/10.1097/MD.0000000000029854
  13. Mirsaeva GK, Khakimova RA. The endothelial dysfunction in patients with arterial hypertension after old hemorrhagic stroke. Klinicheskaia laboratornaia diagnostika. 2017;62(12):725-729. (In Russ.). https://doi.org/10.18821/0869-2084-2017-62-12-725-729
  14. Yada N, Yoshimoto K, Kawashima H, Yoneima R, Nishimura N, Tai Y, Tsushima E, Miyamoto M, Ono S, Matsumoto M, Fujimoto T, Nishio K. Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases. Clinical and Applied Thrombosis/Hemostasis. 2020;26:1076029620938874. https://doi.org/10.1177/1076029620938874
  15. Koiou E, Tziomalos K, Katsikis I, Dinas K, Tsourdi EA, Kandaraki EA, Delkos D, Papadakis E, Panidis D. Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome. Hormones (Athens). 2012;11(1):77-85.  https://doi.org/10.1007/BF03401540
  16. Shan Y, Wang A, Sun Y, Jiang W, Pang B, An Z, Du X, Wang W, Huang Z. Coagulation and fibrinolytic indices during the first trimester of pregnancy in women with polycystic ovary syndrome: a preliminary study. Reproductive Sciences. 2013;20(11):1390-1397. https://doi.org/10.1177/1933719113485293
  17. Vdovichenko JP, Firsova NA, Alipova NF. Hemostasiological aspects of failed in vitro fertilization attempts in women with metabolic syndrome. Reproduktivnoe zdorov’e. Vostochnaya Evropa. 2019; 6(9):755-763. (In Russ.).
  18. Recieved 26.10.2023 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.